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Abstract
Background—TH2-dependent diseases vary in severity according to genotype, but relevant gene
polymorphisms remain largely unknown. The integrin CD11a is a critical determinant of allergic
responses, and allelic variants of this gene might influence allergic phenotypes.
Objective—We sought to determine major CD11a allelic variants in mice and human subjects
and their importance to allergic disease expression.
Methods—We sequenced mouse CD11a alleles from C57BL/6 and BALB/c strains to identify
major polymorphisms; human CD11a single nucleotide polymorphisms were compared with
allergic disease phenotypes as part of the international HapMap project. Mice on a BALB/c or
C57BL/6 background and congenic for the other strain's CD11a allele were created to determine
the importance of mouse CD11a polymorphisms in vivo and in vitro.
Results—Compared with the C57BL/6 allele, the BALB/c CD11a allele contained a
nonsynonymous change from asparagine to aspartic acid within the metal ion binding domain. In
general, the BALB/c CD11a allele enhanced and the C57BL/6 CD11a allele suppressed TH2 cell–
dependent disease caused by the parasite Leishmania major and allergic lung disease caused by
the fungus Aspergillus niger. Relative to the C57BL/6 CD11a allele, the BALB/c CD11a allele
conferred both greater T-cell adhesion to CD54 in vitro and enhanced TH2 cell homing to lungs in
vivo. We further identified a human CD11a polymorphism that significantly associated with atopic
disease and relevant allergic indices.
Conclusions—Polymorphisms in CD11a critically influence TH2 cell homing and diverse TH2-
dependent immunopathologic states in mice and potentially influence the expression of human
allergic disease.
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The mechanisms that control the recruitment, or homing, of TH cells collectively represent
an essential immune regulatory checkpoint that crucially influences outcomes of diverse
infectious and inflammatory processes.1 The homing of TH2 cells is specifically regulated
through the expression and regulation of leukocyte function–associated antigen 1 (LFA-1),
representing the heterodimeric association of CD18 and CD11a.2 In the absence of
stimulation, LFA-1 is maintained in a low-affinity state that weakly binds the LFA-1
receptor CD54 (intercellular adhesion molecule 1) through the inserted (I) domain of
CD11a.3-7 High concentrations of divalent cations stabilize and chemokines activate LFA-1
to a high-affinity state, allowing circulating T cells to tightly adhere to CD54 on endothelial
surfaces and extravasate to sites of inflammation and infection.5,8
In part, the importance of LFA-1 for TH2 cell homing is determined by successive rounds of
cell division during which LFA-1 expression is maintained or enhanced while expression of
alternate homing integrins is reduced.9 Blockade or genetic deletion of LFA-1 does not
interfere with the induction of robust TH2 responses but precludes efficient TH2 cell homing
to sites of infection and inflammation without interfering with the development and homing
of other TH effector subsets.9 Therefore selective blockade of TH2 cell homing through
LFA-1 antagonism results in diverse phenotypes in mice, including reduced expression of
allergic lung disease and improved control of the intramacrophage parasite Leishmania
major in C57BL6 and BALB/c mice.9 The effect of LFA-1 deletion in BALB/c mice is
particularly striking, converting the normally progressive and lethal L major infection into a
transient illness that more closely resembles the disease course of C57BL/6 mice.9
C57BL/6 mice control L major infection by mounting a dominant TH1 immune response,
whereas BALB/c mice do not control the infection because of production of an aberrant
TH2-predominant antiparasite response.10,11 Although several genetic loci have been shown
to contain genes that promote resistance to L major,12 the specific genetic causes for the
dominant TH2 response and susceptibility in BALB/c mice have yet to be clearly defined.13
Airway challenge of C57BL/6 and BALB/c mice with the same allergen also produces
variable immune and physiologic responses, the latter assessed as airway hyperreactivity
(AHR), although allergic eosinophil- and TH2-predominant inflammation is consistently
observed.14 The many genetic factors that underlie the mouse allergic lung inflammatory
response15 overlap considerably with those influencing the mouse response to L major
infection and include CD11a. BALB/c mice that are deficient in CD11a demonstrate
impaired TH2 cell homing to the site of infection and arrested progression of L major
infection, which is similar to the healer phenotype observed in the C57BL/6 mouse strain.9
The apparent increase in resistance in the absence of the BALB/c CD11a allele suggests that
the BALB/c CD11a allele is an important factor in the pathogenesis of L major in the
BALB/c mouse strain. As a gene located within a genomic region identified for carrying L
major resistance in C57BL/6 mice, it is possible that polymorphisms in CD11a might in part
determine the divergent immune and physiologic outcomes of BALB/c and C57BL/6 mice
in models of L major infection and asthma.
To investigate the existence of polymorphisms in CD11a, we sequenced and identified
strain-specific polymorphisms in CD11a of BALB/c and C57BL/6 mice and created mice
congenic for CD11a on the BALB/c and C57BL/6 backgrounds to test the effect of CD11a
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alleles in the TH1- and TH2-mediated disease models of L major infection and allergic lung
disease.
Methods
Mice
Animal studies were conducted under protocols approved by Baylor College of Medicine's
Institutional Animal Care and Use Committee; mice were all housed under specific
pathogen-free conditions and were fed standard mouse chow ad libitum. BALB/c, C57BL/6,
and recombination-activating gene (Rag) 1−/− mice were purchased from Jackson
Laboratories (Bar Harbor, Me). Rag2−/− mice were acquired from Taconic (Hudson, NY).
CD11a−/−mice on the BALB/c (10 generations backcrossed) and C57BL/6 (8 generations
backcrossed) backgrounds were provided by Dr C. M. Ballantyne.16 CD11a-congenic mice
on the BALB/c (BalbC57-CD11a) and C57BL/6 (C57balb-CD11a) backgrounds were created by
crossing CD11a−/− mice of one background with the wild-type (WT) strain of the other
background. Progeny were then backcrossed to the parent CD11a−/− strain, selecting for
CD11a expression on CD4 T cells for 8 generations. Homozygous congenic or litter-mate
CD11a−/− mice were recreated by crossing eighth-generation heterozygous mice and
selecting for complete loss of the targeting construct by using PCR or CD11a by using flow
cytometry, respectively.
L major infection
L major (strain MRHO/SU/59/P/LV39) was cultured and mouse infection was established,
as previously described.17
Macrophage phenotype
Popliteal lymph nodes were harvested from 3-week L major–infected mice and processed
for total RNA by using Trizol (Invitrogen, Carlsbad, Calif), according to the manufacturer's
methods. Primer sets (Applied Biosystems, Foster City, Calif) for inducible nitric oxide
synthase (iNOS; Mm00440502_m;), Arg1 (Mm00475988_m1), found in inflammatory zone
1 (Fizz1; Mm00445109_m1), and 18s RNA (4319413E-0710034) were used to quantify
mRNA with the TaqMan One-Step RT-PCR Master Mix (4309169, Applied Biosystems)
using the 7500 Real-Time PCR System (Applied Biosystems). Signals were used to
calculate relative expression levels in accordance with standard practice and expressed as
the relative expression ratios of select genes.
Dynamic adhesion assay
Adhesion of CD4+ cells was quantitated by means of video microscopy under continuous
flow conditions in vitro.18,19 For further information, see the Methods section in this article's
Online Repository at www.jacionline.org.
Flow cytometry
Lymphocytes were stained with CD4-Pacific Blue, CD3–allophycocyanin, and CD11a–
phycoerythrin (PE), CD11b-PE, or CD11c-PE (all from BD PharMingen, San Jose, Calif) by
using standard staining methods.
Adoptive transfer of ovalbumin-specific CD4+ T cells
Mice were challenged with ovalbumin (OVA)–alum weekly for at least 3 weeks, spleens
were harvested, and CD4+ cells were collected, selected under TH2 responses, differentially
labeled fluorescently, and injected into strainspecific Rag-deficient mice for comparison of
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TH2 cell homing efficiency. For further information, see the Methods section in this article's
Online Repository.
Allergic airway disease
Mice were challenged with a clinical isolate of 4 × 105 Aspergillus niger conidia every 2
days for 8 challenges and assessed for allergic airway disease, as previously described.20
Human single nucleotide polymorphism analysis and correlation
Human studies were conducted under Institutional Review Board–approved protocols at
Harvard Medical School and Brigham and Women's Hospital.
Genotyping and data management
Of the 1041 participating parent-child trios in the Childhood Asthma Management Program
(CAMP) trial,21 92.9% are included in this analysis. Using data from European Americans
(CEU) in the International HapMap project,22 we applied a linkage disequilibrium (LD)–
tagging algorithm (minor allele frequency, ≥10%; r2 > 0.8) to capture common variation in
CD11a and its 10-kb flanks.23 For this study, additional single nucleotide polymorphisms
(SNPs) were genotyped to evaluate reported functional variation (rs) within the genomic
region of CD11a. All SNPs were genotyped with the SEQUENOM iPLEX platform
(Sequenom, San Diego, Calif).24 The 8 polymorphic SNPs successfully genotyped capture
of greater than 84% of the HapMap SNPs with a minor allele frequency of 10% or greater in
CD11a and its 10-kb flanks in CEU trios at an r2 value of greater than 0.8.
Statistical analysis
Mouse statistics were performed, as described previously.25 For human data, the family-
based association analyses in CAMP were performed with the family-based association test
statistic implemented in GoldenHelix PBAT version 3.6.26 In family-based samples Hardy-
Weinberg equilibrium was tested in parental data.
Results
Identification of polymorphisms in CD11a
To determine whether CD11a polymorphisms distinguish the divergent responses of BALB/
c and C57BL/6 mice to L major infection, we first sequenced the full CD11a mRNA from
C57BL/6 and BALB/c mice (GenBank no. JN986841.1, Fig 1). Of 3 variances from the
canonical C57BL/6 sequence, 2 of the polymorphisms were found in the metal ion binding
domain (MIBD) of CD11a, with the C57BL/6 allele encoding asparagine at position 598 and
proline at position 603 and the BALB/c allele encoding aspartic acid and alanine at the same
positions, respectively. The BALB/c allele further contained an additional glutamine at
position 1007 (Fig 1).
Of particular interest were the position 598 and 603 mutations. The change from asparagine
(C57BL/6) to aspartic acid (BALB/c) occurs at a site within the MIBD that is predicted to
directly bind divalent cations, as required for optimal CD11a function (UniProt). The MIBD
is known specifically to regulate the stability and affinity state of LFA-1 and the homing
efficiency of T cells.5 The polymorphisms occurring in the BALB/c CD11a allele effectively
increase the net negative charge within the MIBD, as well as potentially reducing steric
hindrance to cation binding. Together, we hypothesized that this combination of
polymorphisms would enhance the binding of divalent cations by the BALB/c CD11a allele,
leading to an enhanced affinity for CD54 and potentially augmented TH2 cell homing.
Knight et al. Page 4
J Allergy Clin Immunol. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
BALB/c CD11a congenic mice are resistant to L major infection
TH cells from BALB/c mice express more robust TH2 cell development under neutral and
biased in vitro activation conditions, a finding that parallels the enhanced TH2 cell–
dependent susceptibility to L major infection of BALB/c mice.13,27,28 To determine whether
such enhanced TH2 responses ascribed to the BALB/c mouse are in part attributable to
CD11a polymorphisms, we created mice congenic for CD11a on the BALB/c and C57BL/6
backgrounds, termed BalbC57-CD11a and C57Balb-CD11a, respectively, and assessed their
ability to control infection with L major. As expected,9,13,29 wild type C57BL/6 mice
challenged with L major controlled the infection, as indicated by an increase followed by a
reduction in footpad swelling, whereas BALB/c mice were unable to control the infection, as
assessed by progressive footpad swelling (Fig 2, A). C57balb-CD11a mice also controlled
infection as efficiently as WT C57BL/6 mice,13,30 as did BALB/c CD11a−/− mice, as
previously reported.9 In contrast, relative to WT BALB/c mice, congenic BalbC57-CD11a
mice showed a marked attenuation in disease progression (Fig 2, A).
BALB/c mice further showed significantly higher parasite burdens in the footpads than
C57BL/6 mice at both 3 and 6 weeks after L major infection (Fig 2, B and C). In contrast,
both BalbC57-CD11a and BALB/c-CD11a−/−mice had lower footpad parasite burdens
compared with WT BALB/c mice at the 3-week time point. Dissemination of infection from
the footpad to the spleen was observed at 3 weeks in all mice. However, WT BALB/c mice
had significantly higher parasite burdens in the spleen than all groups at both time points
(Fig 2, D and E). Moreover, BALB/c-CD11a−/−and WT C57BL/6 mice resolved splenic
infection by 6 weeks, and although BalbC57-CD11a mice retained spleen parasites at 6 weeks,
the burdens were approximately 10 times lower relative to WT BALB/c mice (Fig 2, E). For
all other parameters, C57balb-CD11a mice did not differ from WT C57BL/6 mice.
The intermediate phenotype of BalbC57-CD11a mice, as assessed based on footpad swelling
caused by L major (Fig 2, A), was reflected in 2 additional immune parameters. First,
relative to WT BALB/c mice, the relative abundance of IL-4–secreting cells, expressed as
the ratio of IL-4–secreting to IFN-γ–secreting cells from popliteal lymph nodes, was lower
in BalbC57-CD11a mice, reflecting more predominant IFN-γ secretion. Second, lymph node
cells of BalbC57-CD11a mice showed significantly lower expression of a marker of
alternatively (ie, TH2 cell) activated macrophages (found in inflammatory zone 1 [Fizz1])
relative to the classically (ie, TH1 cell) activated macrophage marker inducible nitric oxide
synthase relative to WT BALB/c mice (Fig 2, G). Together, these findings demonstrate that
possessing the C57BL/6 variant of CD11a in BALB/c mice can influence the course of L
major infection, favoring weaker TH2 responses and improved disease control.
CD11a polymorphisms influence allergic lung disease
To confirm these findings in a distinct disease model, we next evaluated the effect of CD11a
polymorphisms on the development of infectious allergic lung disease, a disease model in
which CD11a-dependent TH2 cells exert a more dominant role compared with the L major
model.9 WT BALB/c and C57BL/6 mice were challenged intranasally with the conidia of
the fungus A niger and assessed for the development of AHR, an index of airway
obstruction, in response to acetylcholine challenge, airway eosinophilia, and lung and
airway cytokine secretion (Fig 3).20 Based on a much greater increase in respiratory system
resistance induced by acetylcholine relative to naive mice, both BALB/c and C57BL/6 mice
had AHR, although as expected, this IL-13–dependent response was more pronounced in
BALB/c mice (Fig 3, A and B).31,32 However, whereas C57Balb-CD11a mice showed
significantly enhanced AHR, BALB/cC57-CD11a mice showed significantly attenuated AHR
relative to that seen in genotypematched WT control animals. Similarly, conidia-challenged
BalbC57-CD11a mice showed a 2-fold lower recruitment and C57Balb-CD11a mice showed a 2-
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fold higher recruitment of IL-4– secreting cells to the lung when compared with
genotypematched WT control animals (Fig 3, B and D). There were no significant
differences in either bronchoalveolar lavage fluid cellularity, especially eosinophils, or
airway glycoprotein secretion between the 2 congenic strains (see Figs E1 and E2 in this
article's Online Repository at www.jacionline.org). Differences in cellular proliferation
could not account for the differences noted between WT and congenic T cells because TH2
cells from both genotypes proliferated identically in vitro (see Fig E3 in this article's Online
Repository at www.jacionline.org).
Analysis of culture supernatants of lung homogenates from fungus-challenged mice revealed
that BalbC57-CD11a mice secreted less IL-5 and IL-13 relative to WT BALB/c mice, whereas
no significant difference was observed between congenic and WT mice on the C57BL/6
background (Fig 3, E and F). Concentrations of other inflammatory chemokines and
cytokines (CCL11 [eotaxin], IL-17A, and CCL17 [thymus and activation-regulated
chemokine]) did not differ from lung supernatants of the same mice (see Fig E4 in this
article's Online Repository at www.jacionline.org). Thus the BALB/c allele confers
increased susceptibility to the development of allergic lung disease and more efficient
recruitment of IL-4–producing cells to the lungs regardless of the mouse's genetic
background. Conversely, having the C57BL/6 CD11a allele correlated with improved
resistance to allergic lung disease in either strain.
CD11a polymorphisms influence CD54 adhesion and TH2 cell homing in vivo
The previous results are potentially explained by several functions ascribed to LFA-1,
including modulation of T-cell signaling and development, in addition to homing.33-36 Our
prior analysis of CD18 and CD11a function did not reveal an essential role for LFA-1 for
either T-cell proliferation or differentiation but did demonstrate its critical importance for
TH2 cell homing.2,9 To determine whether allelic variants of CD11a similarly affect T-cell
homing, we next sought to demonstrate the effect of polymorphisms of CD11a on adherence
to the LFA-1 receptor CD54 under dynamic flow conditions.9 TH cells derived from WT
BALB/c mice showed the greatest time-dependent adherence to CD54 while rolling when
compared with WT C56BL/6 T cells (Fig 4, A). In contrast, BalbC57-CD11a T cells showed a
marked reduction in the number of rolling cells when compared with WT BALB/c T cells
and were not significantly different from WT C57BL/6 T cells. Conversely, C57Balb-CD11a T
cells showed significantly increased adhesion when compared with both WT C57BL/6 and
BalbC57-CD11a T cells. We also assessed the average velocity of rolling T cells but observed
no strain-specific differences (see Fig E5 in this article's Online Repository at
www.jacionline.org). Differences in CD11a expression or additional integrins known to bind
CD54 (CD11b and CD11c) could explain these results but were not detected (see Fig E6 in
this article's Online Repository at www.jacionline.org). Thus similar to the observed in vivo
phenotypes, allelic variants of CD11a substantially influence the ability of LFA-1 to bind
CD54, with the BALB/c CD11a allele conferring increased adherence and the C57BL/6
CD11a allele conferring reduced adherence under dynamic conditions.
We next examined the role of CD11a polymorphisms on the homing of TH2 cells in vivo.
OVA-specific TH2 cells from WT and congenic mice were fluorescently labeled, combined
in a 1:1 ratio, and adoptively transferred into genotype-appropriate Ragdeficient mice.
Recipient mice were then intranasally challenged with OVA and A niger conidia for 3 days,
and lungs were assessed for the presence of labeled donor T cells (Fig 4, B-D). Although
equivalent donor cells were transferred to each mouse (Fig 4, B, inset), a greater number of
WT BALB/c T cells when compared with BalbC57-CD11a T cells were observed in the lungs
after A niger and OVA challenge (Fig 4, B). The total numbers of lung T cells (see Fig E7 in
this article's Online Repository at www.jacionline.org) and relative percentage of recruited T
Knight et al. Page 6
J Allergy Clin Immunol. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
cells (Fig 4, C) were determined in multiple mice and consistently showed that T cells
containing the BALB/c CD11a allele were more efficient at homing to the lungs, regardless
of the genetic background of the donor mouse (Fig 4, C and D). In contrast, homing of
CD4+ TH1 cells was not affected by CD11a polymorphisms in the in vivo homing model
(Fig 4, E). These experiments show that the BALB/c CD11a allele significantly enhances
the homing efficiency of TH2 cells when compared with the C57BL/6 CD11a allele.
Human CD11a polymorphism correlates to allergic disease
The unexpected importance of allelic variants of CD11a to the expression of mouse allergic
disease suggested that human CD11a allelic variants might have genetic importance. To
begin to determine this, we first identified 16 SNPs in the region of CD11a on chromosome
16 (Fig 5, A) from participants in the CAMP study.21 Two SNPs (rs1064524 and
rs2230433) were found to cause missense mutations and 1 (rs2230434) synonymous
mutation in exons of CD11a. LD analysis showed 3 LD blocks across the CD11a SNPs (Fig
5, B).
Genotyping was performed in 6 SNPs, including the 2 missense mutations. The missense
mutation rs1064524 represents a change from a positive polar (Arg) to a hydrophobic (Trp)
amino acid in the inserted domain of CD11a. Analysis of the transmission of rs1064524
from parents to asthmatic probands in relation to allergic disease phenotypes was analyzed
by using a dominant model of inheritance (Fig 5, C). The frequency of rs1064524 in the
CAMP cohort significantly correlated with the occurrence of multiple allergic disease
phenotypes and TH2 cell activity, including atopic dermatitis (self-report), peripheral blood
eosinophil counts, serum IgE levels, AHR (DRSR), and allergic rhinitis (hay fever; self-
report).
Discussion
The divergent but critical roles of CD11a in regulating the mouse immune and physiologic
responses in models of L major infection and allergic lung disease suggested a broader role
for this adhesion molecule in immune regulation and disease.2,9 We have now identified
distinct alleles for CD11a occurring within BALB/c and C57BL/6 mice that explain in part
the distinct immune responses of these mouse strains. Functionally, the BALB/c CD11a
allele conferred greater adhesion to CD54, more efficient homing of TH2 cells in vivo, and
more robust expression of TH2 cell–dependent disease, including more progressive disease
caused by L major infection and enhanced allergic lung disease. We further identified a
unique allelic variant of CD11a that segregates with multiple indices of human allergic
disease. Together, these findings confirm the importance of CD11a to the expression of
allergic disease through the regulation of TH2 cell homing and provide the first evidence that
polymorphic variants of CD11a are significant disease determinants in human allergic
disease.
The unusual susceptibility of BALB/c mice to L major infection has been studied intensively
for more than 40 years and is known to be both T cell based and polygenic in nature,
involving at least 6 genetic loci.12 Among the many T cell–specific factors linked to
resistance to L major infection, our data indicate that the importance of chromosome 7 to L
major resistance is in part due to CD11a, the gene for which (Itgal) lies within this
chromosome. Replacement of the cognate CD11a allele in BALB/c mice with the C57BL/6
allele improved resistance to L major in mice on the BALB/c background, as assessed based
on reduced, although still progressive, footpad swelling; reduced parasite burdens at
multiple time points; and reduced alternative macrophage activation. Nonetheless, as
expected, the effect was not as pronounced as deletion of CD11a entirely (Fig 2 and Lee et
al9). In contrast, congenic C57BL/6 mice were indistinguishable from WT C57BL/6 mice
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with regard to control of L major infection (Fig 2 and data not shown). Thus CD11a is a
major determinant of resistance to L major infection only in BALB/c mice; other factors are
more important in determining resistance on the C5BL/6 genetic background. These
observations are consistent with the downregulation of LFA-1 expression and CD54-
independent homing that has previously been shown for TH1 cells, which predominate in L
major–infected C57BL/6 mice.9,37
A more consistent role for CD11a allelic variants was evident in experimental allergic lung
disease, a model in which TH2 cells are clearly linked to disease expression across
genotypes.14 Regardless of the mouse genetic background, possession of the BALB/c
CD11a allele resulted in greater AHR, an important disease marker that is strongly
dependent on the recruitment of TH2 cells to the lung.2,9 The BALB/c CD11a allele further
enhanced recruitment to the lung of IL-4–secreting cells and the secretion of allergy-related
cytokines from the lungs of BALB/c mice (Fig 3). A similar effect of the BALB/c allele was
seen in C57BL/6 mice, although enhanced secretion of IL-5 and IL-13 from the lung was
not seen. Thus, as with L major infection, although CD11a is important for disease
expression in both C57BL/6 and BALB/c mice, additional factors in C57BL/6 mice modify
disease expression independently of LFA-1.
Our findings demonstrate that distinct CD11a alleles influence the efficiency of TH2 cell
homing. These observations are entirely consistent with the enhanced adhesion of the
BALB/c CD11a allele to CD54 in vitro (Fig 4, A) and our prior demonstration of the general
importance of CD11a for TH2 cell homing.9 Thus independent of the absolute level of gene
expression, mouse CD11a exists in functionally hypomorphic (ie, the C57BL/6 allele) or
hypermorphic (ie, the BALB/c allele) variants, as assessed by adhesion to CD54, which
critically influence the expression of TH2-dependent diseases, and our preliminary analyses
indicate that the same paradigm is also true in human subjects. Although additional study is
required, we propose that CD11a might confer enhanced or reduced susceptibility to diverse
allergic diseases based on the expressed alleles.
Our findings leave unresolved which amino acid changes or combinations thereof within the
BALB/c CD11a allele determine the enhanced adhesion to CD54. We speculate that the
greater negative charge within the MIBD of the BALB/c allele promotes more robust
interaction with divalent cations, which in turn promotes a more consistently activated
conformation that more efficiently engages CD54.4,38 Similarly, we suspect that the Arg to
Trp change within the inserted domain of the rs1064524 allele of human CD11a also
enhances binding to CD54, although through a mechanism that might not involve cation
binding. Obviously, this allele is not present in the mouse, and hence there is no direct
polymorphism link between our human genetics and the mouse genetics described here.
Therefore much further work is required to resolve the atomic and molecular basis of the
distinct CD11a phenotypes. Clarification of these mechanisms and the improved
understanding of CD11a function that this will bring might provide new insight into the
importance of CD11a as a disease marker and how LFA-1 can be safely manipulated to
improve outcomes for a variety of diseases involving TH2 cells.
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Abbreviations
AHR Airway hyperreactivity
CAMP Childhood Asthma Management Program
LD Linkage disequilibrium
LFA-1 Leukocyte function–associated antigen 1
MIBD Metal ion binding domain, OVA, Ovalbumin
PE Phycoerythrin
Rag Recombination-activating gene
SNP Single nucleotide polymorphism
WT Wild-type
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Key messages
• Polymorphisms in the integrin CD11a in part explain differences in
susceptibility of diverse mouse strains to TH2-dependent disease.
• A distinct SNP in human CD11a is associated with several allergic disease
indices.
• CD11a might represent a useful susceptibility biomarker and therapeutic target
in allergic disease.
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Fig 1.
Mouse CD11a exists in distinct allelic forms. The diagram schematically depicts major
functional domains of the extracellular domain of CD11a and the amino acid differences
between the BALB/c and C57BL/6 mouse strains. TM, Trans-membrane domain.
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Fig 2.
Effect of CD11a polymorphisms on L major infection. A, Footpad swelling of WT
compared with congenic mice infected with L major promastigotes. *P < .001 (n = 5 per
group). B-E, Parasite burdens from footpads and spleens at 3 (Fig 2, B and D) and 6 (Fig 2,
C and E) weeks. *P < .05. F, Ratio of IL-4– and IFN-γ–producing cells from popliteal
lymph nodes at 3 and 6 weeks. *P < .05. G, Ratio of found in inflammatory zone1(Fizz1)/
inducible nitric oxide synthase (iNOS), as assessed by using real-time quantitative PCR.*P<.
05.
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Fig 3.
CD11a polymorphisms influence allergic airway disease. A, Respiratory system resistance
(RRS) values comparing BALB/c and BALB/cC57 congenic mice challenged with PBS or A
niger conidia (AN). *P < .001 (n = 3 for BALB/c mice; n = 5 for all other groups). B, Total
lung IFN-γ– and IL-4–producing cells. *P < .001. C, Respiratory system resistance values
comparing C57BL/6 and C57Balb congenic mice. *P < .05, (n = 5). D, Total lung IFN-γ–
and IL-4–producing cells. *P < .001. E and F, IL-5 and IL-13 levels from lung
homogenates. *P < .05 (n = 5). Ach, Acetylcholine; ND, not detectable.
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Fig 4.
CD11a polymorphisms influence TH2 cell homing. A, T-cell adhesion to CD54 under
dynamic flow. *P < .05 (n = 3). B-E, Rag-deficient mice were reconstituted with labeled
TH2 cells from WT and congenic mice, respectively (Fig 4, B, inset) and intranasally
challenged with A niger/OVA to induce T-cell recruitment, after which lung-derived single-
cell suspensions were analyzed for donor TH2 (Fig 4, B [n = 1]; C, and D) and TH1 (Fig 4,
E) cells. *P < .05. Data from one of 3 comparable experiments analyzing 1 × 106 cells per
lung.
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Fig 5.
Association of human CD11a SNPs to allergic disease. A, Location of SNPs within the
human CD11a locus; exons are indicated in gray. B, Pairwise r2 values for correlations
between identified SNPs. Black squares, r2 = 1; white squares, r2 = 0; gray squares, 0 < r2 <
1 with intensity proportional to r2. C, Significant correlations between SNPs and the
indicated allergy phenotypes. DRSR, Log of dose-response slope to methacholine challenge;
ns, not significant; HAYF, hay fever.
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